Perspective Therapeutics ... (CATX)

1.95

-0.18 (-8.45%)

At close: Apr 01, 2025, 3:59 PM

2.06

5.70%

After-hours: Apr 01, 2025, 08:00 PM EDT

Perspective Therapeutics Cash Flow Statement

Chart Mode

Year	FY23	FY22	FY21	FY20	FY19
Net Income	-46.51M	-14.67M	-7.27M	-3.39M	-3.45M
Depreciation & Amortization	946K	344K	248K	149K	147K
Stock-Based Compensation	3.74M	1.34M	1.09M	386K	495K
Other Working Capital	779K	n/a	182K	100K	181K
Other Non-Cash Items	5.27M	472K	77K	72K	-2K
Deferred Income Tax	-2.65M	-1.68M	n/a	10K	n/a
Change in Working Capital	2.3M	338K	-1.85M	-67K	-835K
Operating Cash Flow	-36.91M	-12.17M	-7.71M	-2.84M	-3.64M
Capital Expenditures	-1.07M	-302K	-266K	-381K	-273K
Acquisitions	2.7M	n/a	n/a	1K	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	22.76M	n/a	n/a	n/a	n/a
Other Investing Acitivies	-18K	-57.38M	-18K	-30K	-14K
Investing Cash Flow	24.37M	-57.68M	-284K	-410K	-287K
Debt Repayment	-68K	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	-9K	-11K
Other Financial Acitivies	489K	56K	n/a	n/a	n/a
Financial Cash Flow	785K	56K	56K	64.68M	994K
Net Cash Flow	-46.65M	182K	-7.94M	61.44M	-2.93M
Free Cash Flow	-37.98M	-12.47M	-7.98M	-3.22M	-3.91M